1. Home
  2. TVRD vs OBT Comparison

TVRD vs OBT Comparison

Compare TVRD & OBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • OBT
  • Stock Information
  • Founded
  • TVRD 2017
  • OBT 1892
  • Country
  • TVRD United States
  • OBT United States
  • Employees
  • TVRD N/A
  • OBT N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • OBT Major Banks
  • Sector
  • TVRD Health Care
  • OBT Finance
  • Exchange
  • TVRD Nasdaq
  • OBT Nasdaq
  • Market Cap
  • TVRD 246.5M
  • OBT 294.2M
  • IPO Year
  • TVRD N/A
  • OBT N/A
  • Fundamental
  • Price
  • TVRD $26.91
  • OBT $27.77
  • Analyst Decision
  • TVRD Strong Buy
  • OBT Buy
  • Analyst Count
  • TVRD 4
  • OBT 1
  • Target Price
  • TVRD $58.50
  • OBT $35.50
  • AVG Volume (30 Days)
  • TVRD 92.7K
  • OBT 106.2K
  • Earning Date
  • TVRD 08-21-2025
  • OBT 07-30-2025
  • Dividend Yield
  • TVRD N/A
  • OBT 1.89%
  • EPS Growth
  • TVRD N/A
  • OBT N/A
  • EPS
  • TVRD N/A
  • OBT 2.41
  • Revenue
  • TVRD N/A
  • OBT $100,883,000.00
  • Revenue This Year
  • TVRD N/A
  • OBT $18.39
  • Revenue Next Year
  • TVRD N/A
  • OBT $7.98
  • P/E Ratio
  • TVRD N/A
  • OBT $11.42
  • Revenue Growth
  • TVRD N/A
  • OBT N/A
  • 52 Week Low
  • TVRD $8.13
  • OBT $20.97
  • 52 Week High
  • TVRD $34.31
  • OBT $33.06
  • Technical
  • Relative Strength Index (RSI)
  • TVRD N/A
  • OBT 68.20
  • Support Level
  • TVRD N/A
  • OBT $26.67
  • Resistance Level
  • TVRD N/A
  • OBT $27.86
  • Average True Range (ATR)
  • TVRD 0.00
  • OBT 0.96
  • MACD
  • TVRD 0.00
  • OBT 0.31
  • Stochastic Oscillator
  • TVRD 0.00
  • OBT 89.59

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

Share on Social Networks: